PULMONX CORPORATION (LUNG) Current Ratio
- Current ratio · latest quarter: Value 4.32×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.32× | Current assets / current liabilities. $88.13M ÷ $20.41M ≈ 4.32× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 88.13M USD | Assets, Current |
| Current obligations | 20.41M USD | Liabilities, Current |
| Cash and equivalents | 55.84M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 12.25M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 16.39M USD | Inventory, Net |
| Payables | 4.67M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $88.13M | $20.41M | $55.84M | (m) | $12.25M | $16.39M | $4.67M | (m) | 4.32× |
| 2026-03-31 | $92.75M | $18.91M | $61.57M | (m) | $10.83M | $16.31M | $3.47M | (m) | 4.91× |
| 2025-12-31 | $101.68M | $20.06M | $69.75M | (m) | $12.07M | $15.85M | $3.90M | (m) | 5.07× |
| 2025-09-30 | $111.23M | $22.88M | $76.55M | (m) | $13.80M | $16.25M | $6.42M | (m) | 4.86× |
| 2025-06-30 | $120.02M | $22.45M | $75.47M | (m) | $15.90M | $16.18M | $6.56M | (m) | 5.35× |
| 2025-03-31 | $123.94M | $24.95M | $74.56M | (m) | $13.97M | $16.81M | $4.28M | (m) | 4.97× |
| 2024-12-31 | $136.25M | $24.44M | $70.91M | (m) | $13.12M | $16.91M | $3.83M | (m) | 5.58× |
| 2024-09-30 | $140.93M | $18.30M | $63.31M | (m) | $11.67M | $16.96M | $4.58M | (m) | 7.70× |
| 2024-06-30 | $146.16M | $16.30M | $63.46M | (m) | $11.08M | $16.98M | $3.18M | (m) | 8.97× |
| 2024-03-31 | $147.94M | $21.29M | $70.16M | (m) | $10.52M | $17.23M | $3.13M | (m) | 6.95× |
| 2023-12-31 | $150.42M | $23.16M | $83.55M | (m) | $12.11M | $16.74M | $1.50M | (m) | 6.50× |
| 2023-09-30 | $147.36M | $20.48M | $94.94M | (m) | $10.09M | $16.13M | $3.19M | (m) | 7.19× |
| 2023-06-30 | $164.43M | $19.52M | $101.58M | $33.57M | $8.94M | $15.64M | $2.38M | (m) | 8.42× |
| 2023-03-31 | $181.30M | $17.08M | $110.41M | $42.43M | $8.17M | $15.59M | $2.89M | (m) | 10.62× |
| 2022-12-31 | $168.95M | $18.49M | $101.74M | (m) | $8.68M | $14.56M | $1.76M | (m) | 9.14× |
| 2022-09-30 | $183.11M | $21.69M | $112.40M | $44.50M | $7.22M | $15.57M | $2.65M | (m) | 8.44× |
| 2022-06-30 | $192.78M | $20.45M | $121.95M | $40.14M | $7.52M | $19.21M | $2.60M | (m) | 9.43× |
| 2022-03-31 | $200.72M | $17.71M | $129.17M | $40.91M | $6.81M | $18.30M | $2.80M | (m) | 11.33× |
| 2021-12-31 | $208.00M | $17.55M | $148.48M | $31.56M | $6.56M | $16.29M | $1.58M | (m) | 11.85× |
| 2021-09-30 | $227.64M | $22.22M | $188.07M | $11.77M | $6.92M | $14.98M | $4.43M | $3.31M | 10.25× |
| 2020-12-31 | $249.99M | $12.53M | $231.56M | $0.00 | $4.23M | $10.74M | $1.47M | (m) | 19.96× |
| 2020-09-30 | $55.62M | $15.17M | $39.81M | $0.00 | $5.26M | $9.29M | $2.30M | (m) | 3.67× |
| 2019-12-31 | $41.07M | $14.16M | $14.77M | $13.58M | $5.51M | $5.61M | $2.68M | (m) | 2.90× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |